Sol Gel Technologies Ltd
NASDAQ:SLGL

Watchlist Manager
Sol Gel Technologies Ltd Logo
Sol Gel Technologies Ltd
NASDAQ:SLGL
Watchlist
Price: 57.34 USD -1.88% Market Closed
Market Cap: $159.7m

Net Margin

-47.4%
Current
Improving
by 697.1%
vs 3-y average of -744.5%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-47.4%
=
Net Income
$-9m
/
Revenue
$19m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-47.4%
=
Net Income
$-9m
/
Revenue
$19m

Peer Comparison

Country Company Market Cap Net
Margin
IL
Sol Gel Technologies Ltd
NASDAQ:SLGL
159.7m USD
Loading...
US
Eli Lilly and Co
NYSE:LLY
992.9B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
541.8B USD
Loading...
CH
Roche Holding AG
SIX:ROG
278.2B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
216.3B GBP
Loading...
CH
Novartis AG
SIX:NOVN
223.2B CHF
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
US
Merck & Co Inc
NYSE:MRK
269.1B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
151B USD
Loading...
FR
Sanofi SA
PAR:SAN
97.1B EUR
Loading...

Market Distribution

Lower than 79% of companies in Israel
Percentile
21st
Based on 749 companies
21st percentile
-47.4%
Low
-85 210% — -8.6%
Typical Range
-8.6% — 7.2%
High
7.2% — 23 652.1%
Distribution Statistics
Israel
Min -85 210%
30th Percentile -8.6%
Median 1.8%
70th Percentile 7.2%
Max 23 652.1%

Sol Gel Technologies Ltd
Glance View

Market Cap
159.7m USD
Industry
Pharmaceuticals

Sol-Gel Technologies Ltd. is a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. The firm is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The firm is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.

SLGL Intrinsic Value
17.26 USD
Overvaluation 70%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-47.4%
=
Net Income
$-9m
/
Revenue
$19m
What is Sol Gel Technologies Ltd's current Net Margin?

The current Net Margin for Sol Gel Technologies Ltd is -47.4%, which is above its 3-year median of -744.5%.

How has Net Margin changed over time?

Over the last 3 years, Sol Gel Technologies Ltd’s Net Margin has decreased from 19.9% to -47.4%. During this period, it reached a low of -2 343.4% on Sep 30, 2023 and a high of 19.9% on Aug 30, 2022.

Back to Top